Vincent J. Angotti
Net Worth

Last updated:

What is Vincent J. Angotti net worth?

The estimated net worth of Mr. Vincent J. Angotti is at least $7,459,760 as of 13 Dec 2023. He has received compensation worth at least $7,459,760 in AcelRx Pharmaceuticals, Inc..

What is the salary of Vincent J. Angotti?

Mr. Vincent J. Angotti salary is $932,470 per year as Chief Executive Officer & Director in AcelRx Pharmaceuticals, Inc..

How old is Vincent J. Angotti?

Mr. Vincent J. Angotti is 57 years old, born in 1968.

What stocks does Vincent J. Angotti currently own?

As insider, Mr. Vincent J. Angotti owns shares in one company:

Company Title Shares Price per share Total value
AcelRx Pharmaceuticals, Inc. (ACRX) Chief Executive Officer & Director 101,805 $0 $0

What does AcelRx Pharmaceuticals, Inc. do?

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.

ACRX logo
ACRX
AcelRx Pharmaceuticals, Inc.

Vincent J. Angotti insider trading

AcelRx Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 $0.73 $7,270
Purchase
Common Stock 10,000 $0.8 $7,950
Purchase
Common Stock 46,400 $0.22 $10,347
Purchase
Common Stock 7,547 $1.33 $10,038
Purchase
Common Stock 8,379 $1.79 $14,973
Purchase
Common Stock 5,000 $2.31 $11,550
Purchase
Common Stock 3,234 $2.81 $9,088
Purchase
Common Stock 3,610 N/A N/A
Purchase
Common Stock 10,000 $2.99 $29,890
Purchase
Common Stock 10,000 $2.9 $28,950
Purchase
Common Stock 15,000 $3 $45,000

AcelRx Pharmaceuticals key executives

AcelRx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: